Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery.
- 1 November 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9346) , 1701
- https://doi.org/10.1016/S0140-6736(02)11636-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Fondaparinux: a new synthetic pentasaccharide for thrombosis preventionThe Lancet, 2002
- Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonThe Lancet, 2002
- Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialThe Lancet, 2002
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryNew England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryNew England Journal of Medicine, 2001